4.7 Article

Pregnancy Zone Protein as an Emerging Biomarker for Cardiovascular Risk in Pediatric Chronic Kidney Disease

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction

Ingrid K. Fosheim et al.

Summary: Hypertensive disorders of pregnancy, diabetes mellitus, and placental dysfunction are associated with increased risk of long-term maternal cardiovascular disease. Serum amyloid A1 and pregnancy zone protein are dysregulated in early-onset preeclampsia and placental dysfunction, contributing to future maternal cardiovascular disease.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2023)

Article Peripheral Vascular Disease

Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association

Joseph T. Flynn et al.

Summary: The use of ambulatory blood pressure monitoring in children and adolescents has increased significantly, as has the evidence base for its use. This scientific statement provides a concise review of the new evidence, guidance on optimal application of ambulatory blood pressure monitoring in the clinical setting, and an updated classification scheme for interpretation. Areas of uncertainty requiring further research are also highlighted.

HYPERTENSION (2022)

Review Pediatrics

Advances in proteomic profiling of pediatric kidney diseases

Timothy D. Cummins et al.

Summary: Early diagnosis and detailed understanding of the pathogenesis of chronic kidney disease are crucial in delaying disease progression, but clinical diagnosis often lags behind, making proteomics technologies essential in identifying novel biomarkers for better diagnosis and prognosis.

PEDIATRIC NEPHROLOGY (2022)

Article Biochemistry & Molecular Biology

Complement Factor H and Related Proteins as Markers of Cardiovascular Risk in Pediatric Chronic Kidney Disease

Wei-Ting Liao et al.

Summary: Cardiovascular disease is the leading cause of death among patients with chronic kidney disease, including both adults and children. Hypertension is one of the risk factors for cardiovascular disease. Monitoring blood pressure, cardiac sonography, and assessing arterial stiffness can help detect subclinical cardiovascular disease in pediatric chronic kidney disease patients. Congenital anomalies of the kidney and urinary tract are the main causes of pediatric chronic kidney disease. Complement factor H and related proteins are associated with cardiovascular disease risk in children with chronic kidney disease.

BIOMEDICINES (2022)

Article Immunology

The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients

Sanja Loeb et al.

Summary: PZP and EFTUD2 might play important roles in the development of placental dysfunction in preeclampsia and HELLP syndrome.

JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2022)

Review Pediatrics

Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease

You-Lin Tain et al.

Summary: Hypertension is a common complication of chronic kidney disease (CKD) in children and is strongly associated with subsequent cardiovascular disease (CVD). However, there is a lack of research on ideal biomarkers in pediatric CKD. This review aims to summarize the current knowledge on hypertension, cardiovascular risk factors, and potential CVD markers/biomarkers in children with pre-dialysis CKD. The challenges and limited research on pediatric CKD are discussed, highlighting the need for further efforts in evaluating CVD biomarkers for clinical practice in pediatric CKD.

CHILDREN-BASEL (2022)

Review Biochemistry & Molecular Biology

Urinary Protein and Peptide Markers in Chronic Kidney Disease

Natalia Chebotareva et al.

Summary: CKD is a non-specific kidney disease that causes gradual decline in kidney function, posing significant risks for death and other complications. Protein/peptide biomarkers can be used for early non-invasive diagnosis and may provide new approaches for targeted therapy. Mass spectrometry approaches offer valuable insights into understanding CKD progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Cardiorenal Syndrome: New Pathways and Novel Biomarkers

Guido Gembillo et al.

Summary: Cardiorenal syndrome is a multi-organ disease involving complex interactions between the heart and kidney, with the use of specific biomarkers aiding in diagnosis, risk assessment, and prognosis determination.

BIOMOLECULES (2021)

Article Pediatrics

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III

Wei-Ling Chen et al.

Summary: The study identified 20 differentially expressed proteins associated with hypertension in children with CKD, with apolipoprotein C-II being the most abundant among CKD patients. Children with CKD stages G2-G4 had higher plasma apoC-II levels.

FRONTIERS IN PEDIATRICS (2021)

Review Urology & Nephrology

Plasma and Urine Biomarkers of CKD: A Review of Findings in the CKiD Study

Ibrahim Sandokji et al.

Summary: Serum creatinine and proteinuria, traditional biomarkers of chronic kidney disease (CKD) progression, do not fully explain the variability of glomerular filtration rate decline and are late markers. Recent studies have identified novel plasma and urine biomarkers at higher levels in children with CKD, independently associated with CKD progression, even after adjustment for serum creatinine and proteinuria.

SEMINARS IN NEPHROLOGY (2021)

Review Biochemical Research Methods

Proteomics and personalized medicine: a focus on kidney disease

Justyna Siwy et al.

EXPERT REVIEW OF PROTEOMICS (2019)

Article Biochemistry & Molecular Biology

The Association between Nitric Oxide Pathway, Blood Pressure Abnormalities, and Cardiovascular Risk Profile in Pediatric Chronic Kidney Disease

Chien-Ning Hsu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pediatrics

Emerging biomarkers of chronic kidney disease in children

Jason H. Greenberg et al.

PEDIATRIC NEPHROLOGY (2018)

Review Pediatrics

Role of hypertension in progression of chronic kidney disease in children

Smitha R. Vidi

CURRENT OPINION IN PEDIATRICS (2018)

Article Urology & Nephrology

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease

Allan J. Collins et al.

KIDNEY INTERNATIONAL SUPPLEMENTS (2015)

Article Urology & Nephrology

Timing and Outcome of Renal Replacement Therapy in Patients with Congenital Malformations of the Kidney and Urinary Tract

Elke Wuehl et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)

Review Pediatrics

Cardiovascular risk assessment in children with chronic kidney disease

Rukshana Shroff et al.

PEDIATRIC NEPHROLOGY (2013)

Review Urology & Nephrology

Cardiovascular Disease in Children with Chronic Kidney Disease

Mark M. Mitsnefes

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

Article Transplantation

Novel perspectives for investigating congenital anomalies of the kidney and urinary tract (CAKUT)

Kirsten Y. Renkema et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)

Article Urology & Nephrology

Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKD

Mark Mitsnefes et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Article Urology & Nephrology

New Equations to Estimate GFR in Children with CKD

George J. Schwartz et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Review Pharmacology & Pharmacy

The L-arginine paradox:: Importance of the L-arginine/asymmetrical dimethylarginine ratio

Stefanie M. Bode-Boeger et al.

PHARMACOLOGY & THERAPEUTICS (2007)

Article Transplantation

Cardiovascular risk in end-stage renal disease: vascular aspects

GM London et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)